Copy
Be kind, for every one you meet may be fighting a harder battle than you  - Plato 
View this email in your browser
Our Next Medtronic Bladder Control Therapy (Sacral Neuromodulation) Test Date is: Friday Oct. 21, 2016.
Test stimulation is an appropriate test for people who have failed Overactive Bladder medications.

 
Dr. Boone’s Clinical Use of Testosterone Replacement Vindicated by Swedish Study!
 
The FDA has made bold and negative statements about the use of testosterone therapy in America.
Dr. Boone’s clinical experience has been very different from the government’s current recommendations.
A recently published study from Sweden shows the following:
1. NO increased risk for prostate cancer in men on testosterone therapy.
2. Among 38,570 men diagnosed with prostate cancer in Sweden, less than 1% had ever had testosterone therapy.
3. NO correlation between using testosterone, regardless of the delivery system (gel, shot, pellets), and prostate cancer was found.
4. MOST INTERESTING OF ALL WAS THAT THE WORSE PROSTATE CANCERS OCCURRED IN THE MEN WITH THE LOWEST SERUM TESTOSTERONE LEVELS!
Could our government be wrong?
This study suggests that having a low testosterone could be a contributing factor in prostate cancer pathology. Of course, this study had few patients of Asian, Latin and African descent and cannot be extrapolated to the general public without taking ethnicity into account.
Several IC patients with chronic pain have used this hypnotherapist with great benefit!
Dr. Boone suggests hypnotherapy for anyone with chronic pain.

Inga Chamberlain, M.S., BCHT, RBT
Atlanta Center for Behavioral Change &Neurosolutions
800 Mt. Vernon Highway NE, Suite 300
Atlanta, GA 30328
Phone: (404) 277-1827
 
Cialis Coupons in the office
Save up to $200 on a new Calais prescription 

Note the coupon program does NOT apply to any government insurance program (Medicare)
Patient Portal
Our Website
PLEASE DO NOT REPLY TO THIS EMAIL.
this email is sent from an unmonitored email address


Copyright © 2016 Dr. Martha B. Boone, All rights reserved.



unsubscribe from this list  

 update subscription preferences